The influence of polycystic ovary syndrome on abortion rate after in vitro fertilization/intracytoplasmic sperm injection fresh cycle pregnancy.

Autor: Dou Q; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Ma LY; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Li PF; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Xu XT; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Yu G; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Zhang D; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Xiang YG; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China., Tan L; Department of Reproductive Medicine, The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road, Zhengzhou, 450014, China. tanli@zzu.edu.cn.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2023 Apr 12; Vol. 13 (1), pp. 5978. Date of Electronic Publication: 2023 Apr 12.
DOI: 10.1038/s41598-023-32988-5
Abstrakt: There are many reports on clinical pregnancy outcomes in polycystic ovary syndrome (PCOS) patients receiving vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), but little research about abortion has been done and there is a debate on whether the abortion risk increases in PCOS patients receiving IVF/ICSI. Therefore, the aim of this study was to investigated the abortion in PCOS patients. Clinical data of 12055 IVF/ICSI fresh cycles performed in our hospital from January 2015 to December 2020 were collected. Based on the Rotterdam diagnostic criteria of PCOS and after propensity score matching (PSM) for baseline data of clinical pregnancy cycles, matched 599 PCOS (PCOS group) and Non-PCOS (non-PCOS group) cycles were obtained. Abortion and abortion-related outcomes were compared between the two groups. Risk factors for late abortion in twins were analyzed using binary Logistics regression. Post-PSM data showed that the late abortion rate was significantly higher in the PCOS group than in the non-PCOS group only in twin pregnancy (9.50% vs. 3.96%, OR: 2.55, 95%CI 1.10-5.89). There were no statistical differences in other pregnancy outcomes. The etiological distribution for late abortion were not statistically different between the two groups in both singletons and twins. Logistics regression indicated that PCOS and obesity [pregnancy-assisted body mass index (BMI) ≥ 28] were risk factors for late abortion in twin pregnancy. In twin pregnancy, PCOS and obese patients are more likely to have late abortion. In twin pregnancy, the late abortion risk significantly increased in the PCOS patients as compared with non-PCOS patients (OR: 2.59, 95%CI 1.11-6.03, P < 0.05), as well as in the patients with obesity (BMI ≥ 28) as compared with the patients with normal BMI (OR: 4.17, 95%CI 1.59-10.90, P < 0.05). PCOS does not significantly affect early and overall late abortion rates after IVF/ICSI fresh cycle pregnancy.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje